INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, cilt.20, sa.6, ss.1057-1062, 2015 (SCI-Expanded)
Background Our aim was to evaluate whether it is safe to use a totally implantable venous access device (TIVAD) on the day of implantation.